SciVision Biotech Inc Market Cap ($104.43 Million)
Market Cap & Net Worth: SciVision Biotech Inc (1786)
SciVision Biotech Inc market cap. SciVision Biotech Inc (TW:1786) has a market capitalization of $104.43 Million (NT$3.31 Billion) as of November 4, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #18839 globally and #1045 in its home market, demonstrating a 14.86% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SciVision Biotech Inc's stock price NT$45.60 by its total outstanding shares 72691641 (72.69 Million). Also see SciVision Biotech Inc (1786) cash flow conversion for how efficiently the company converts equity into cash flow.
SciVision Biotech Inc Market Cap History (2015–2026)
SciVision Biotech Inc market cap history from 2015 to 2026. Data shows change from $127.58 Million to $104.43 Million (-1.55% CAGR). Check today's stock price for SciVision Biotech Inc for real-time trading data and today's change.
SciVision Biotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SciVision Biotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore SciVision Biotech Inc net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.19x
SciVision Biotech Inc's market cap is 0.19 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.02x
SciVision Biotech Inc's market cap is 1.02 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $115.74 Million | $228.30 Million | -$26.26 Million | 0.51x | N/A |
| 2017 | $74.03 Million | $258.42 Million | $17.14 Million | 0.29x | 4.32x |
| 2018 | $135.18 Million | $329.58 Million | $86.87 Million | 0.41x | 1.56x |
| 2019 | $149.84 Million | $437.87 Million | $120.70 Million | 0.34x | 1.24x |
| 2020 | $131.17 Million | $466.88 Million | $128.00 Million | 0.28x | 1.02x |
| 2021 | $107.34 Million | $505.54 Million | $101.72 Million | 0.21x | 1.06x |
| 2022 | $121.61 Million | $557.35 Million | $141.72 Million | 0.22x | 0.86x |
| 2023 | $177.72 Million | $712.99 Million | $177.90 Million | 0.25x | 1.00x |
| 2024 | $238.18 Million | $883.31 Million | $242.25 Million | 0.27x | 0.98x |
| 2025 | $166.27 Million | $886.62 Million | $162.34 Million | 0.19x | 1.02x |
Competitor Companies of 1786 by Market Capitalization
Companies near SciVision Biotech Inc in the global market cap rankings as of November 4, 2026. Also see 1786 current and non-current assets for a full breakdown of the balance sheet.
Key companies related to SciVision Biotech Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #175 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $99.74 Billion USD ( €85.32 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #418 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #535 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #175 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $440.75 |
| #258 | EssilorLuxottica S. A. | PA:EL | $99.74 Billion | €184.25 |
| #418 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €91.50 |
| #535 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of SciVision Biotech Inc (2015–2026)
Market capitalization of SciVision Biotech Inc from 2015 to today. Between 2015 and today, SciVision Biotech Inc's market cap moved from $127.58 Million to $ 104.43 Million, with a yearly change of -1.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$104.43 Million | -37.19% |
| 2025 | NT$166.27 Million | -30.19% |
| 2024 | NT$238.18 Million | +34.02% |
| 2023 | NT$177.72 Million | +46.14% |
| 2022 | NT$121.61 Million | +13.29% |
| 2021 | NT$107.34 Million | -18.16% |
| 2020 | NT$131.17 Million | -12.46% |
| 2019 | NT$149.84 Million | +10.84% |
| 2018 | NT$135.18 Million | +82.60% |
| 2017 | NT$74.03 Million | -36.03% |
| 2016 | NT$115.74 Million | -9.28% |
| 2015 | NT$127.58 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of SciVision Biotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $104.43 Million USD |
| MoneyControl | $104.43 Million USD |
| MarketWatch | $104.43 Million USD |
| marketcap.company | $104.43 Million USD |
| Reuters | $104.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SciVision Biotech Inc
SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was fo… Read more